Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · IEX Real-Time Price · USD
39.27
-1.92 (-4.66%)
Jul 2, 2024, 4:00 PM EDT - Market closed
PRAX Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for PRAX stock have an average target of 118.43, with a low estimate of 29 and a high estimate of 155. The average target predicts an increase of 201.58% from the current stock price of 39.27.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for PRAX stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 5 |
| Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Hold | 2 | 2 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 4 | 4 | 5 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Initiates $145 | Strong Buy | Initiates | $145 | +269.24% | Jun 24, 2024 |
| Guggenheim | Guggenheim | Strong Buy Initiates $155 | Strong Buy | Initiates | $155 | +294.70% | Jun 18, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $150 | Strong Buy | Maintains | $150 | +281.97% | May 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $105 | Strong Buy | Reiterates | $105 | +167.38% | May 14, 2024 |
| Baird | Baird | Buy Initiates $117 | Buy | Initiates | $117 | +197.94% | May 1, 2024 |
Financial Forecast
Revenue This Year
1.99M
from 2.45M
Decreased by -18.76%
Revenue Next Year
862.62K
from 1.99M
Decreased by -56.61%
EPS This Year
-10.30
from -18.69
EPS Next Year
-9.97
from -10.30
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 5.7M | 3.2M | 268.7M | 599.3M | 1.1B |
| Avg | 2.0M | 862,624 | 70.5M | 167.8M | 367.9M |
| Low | n/a | n/a | 784,000 | 44.2M | 145.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 131.7% | 58.5% | 31,050.3% | 749.9% | 547.4% |
| Avg | -18.8% | -56.6% | 8,074.4% | 137.9% | 119.3% |
| Low | - | - | -9.1% | -37.4% | -13.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -8.79 | -7.05 | 1.98 | 21.12 | 44.29 |
| Avg | -10.30 | -9.97 | -7.22 | -2.21 | 7.36 |
| Low | -12.20 | -12.03 | -12.96 | -9.01 | -6.99 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.